Dynavax Technologies | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
AbbVie USD 5.52B 1.73B 2024-12
Adma Biologics USD 103.15M 16.44M 2024-12
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Dynavax Technologies USD 661.34M 565.45M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Merck USD 8.63B 4.61B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
TG Therapeutics USD 179.89M 15.93M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Dynavax Technologies Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.